Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Withdrawn 1 Unknown 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 1 Motor Activity 1

Interventions

pembrolizumab 19 Docetaxel 16 Magnetic Resonance Spectroscopy 14 Prednisone 13 Radiotherapy 11 bicalutamide 10 Leuprolide 10 Abiraterone Acetate 9 Radiosurgery 8 Cyclophosphamide 8 Biopsy 8 avelumab 7 atezolizumab 6 Specimen Handling 6 Interleukin-2 6 Gemcitabine 6 Bevacizumab 6 Androgen Antagonists 6 tremelimumab 5 gallium 68 PSMA-11 5 apalutamide 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5 Surveys and Questionnaires 5 Sunitinib 5 Paclitaxel 5 Metformin 5 Injections 5 Goserelin 5 Cisplatin 5 ALT-803 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × High-Intensity Interval Training × Genitourinary × Clear all

NCT05156372 2024-02-26

HIIT PCa

The University of Texas Health Science Center at San Antonio

Phase NA Withdrawn

Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡